A Study of Neoadjuvant FOLFIRINOX and FDR-Gemcitabine With Concurrent IMRT in Patients
Clinical trial NCT01661088 · COMPLETED
Trial details
- NCT number
- NCT01661088
- Sponsor
- University of Michigan Rogel Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-06-01
- Primary completion
- 2017-08-10
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.